Inhibition of these pro‐apoptotic, pro‐degradation and pro‐inflammatory effects induced by S100A9 in NP may be a favourable therapeutic strategy to slow lumbar disc degeneration. This evidence concerns the gene S100A9 and lumbar disk degenerative disorder.